Page 174 - Development Group News Today

On 1 March, Marc Angel, a Member of the European Parliament and former champion for the 90–90–90 HIV targets, hosted a virtual Zero Discrimination Day parliamentary event. The event, co-organized by the Global Partnership for Action to Eliminate all Forms of HIV-Related Stigma and Discrimination (Global Partnership), brought together high-level speakers who are passionate

The antiviral drug molnupiravir is conditionally recommended for patients with non-severe covid-19 who are at highest risk of hospitalization, says a WHO Guideline Development Group of international experts in The BMJ today.

The drug is conditionally recommended, said the WHO Guideline Development Group of international experts in The British Medical Journal (BMJ).

Recommendation based on new data from six clinical trials involving 4,796 patients

The event showcases new technologies in the medical industry and brings together industry stakeholders to help further innovations.

Investegate announcements from Logistics Dev Grp, Holding(s) in Company

Scientists from the University of California (UCLA) have created an exclusive design of ultrathin films for extremely flexible yet mechanically strong bioelectronic membranes that could open doors for diagnostic on-skin sensors that can be positioned precisely over the body’s contours and adapt to its movements.

Investegate announcements from Logistics Dev Grp, Transaction in Own Shares

Investegate announcements from Logistics Dev Grp, Transaction in Own Shares

Job: RF/Opto Test Engineer - KYOCERA SLD Laser, Inc. Goleta, CA, United States